1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Peptides Biosimilars Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Glucagon 1.2.3 Calcitonin 1.3 Market by Application 1.3.1 Global Peptides Biosimilars Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Oncology 1.3.3 Chronic Diseases 1.3.4 Autoimmune Diseases 1.3.5 Blood Disorders 1.3.6 Growth Hormone Deficiency 1.3.7 Infectious Diseases 1.3.8 Other Diseases 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Peptides Biosimilars Market Perspective (2016-2027) 2.2 Peptides Biosimilars Growth Trends by Regions 2.2.1 Peptides Biosimilars Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Peptides Biosimilars Historic Market Share by Regions (2016-2021) 2.2.3 Peptides Biosimilars Forecasted Market Size by Regions (2022-2027) 2.3 Peptides Biosimilars Industry Dynamic 2.3.1 Peptides Biosimilars Market Trends 2.3.2 Peptides Biosimilars Market Drivers 2.3.3 Peptides Biosimilars Market Challenges 2.3.4 Peptides Biosimilars Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Peptides Biosimilars Players by Revenue 3.1.1 Global Top Peptides Biosimilars Players by Revenue (2016-2021) 3.1.2 Global Peptides Biosimilars Revenue Market Share by Players (2016-2021) 3.2 Global Peptides Biosimilars Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Peptides Biosimilars Revenue 3.4 Global Peptides Biosimilars Market Concentration Ratio 3.4.1 Global Peptides Biosimilars Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Peptides Biosimilars Revenue in 2020 3.5 Peptides Biosimilars Key Players Head office and Area Served 3.6 Key Players Peptides Biosimilars Product Solution and Service 3.7 Date of Enter into Peptides Biosimilars Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Peptides Biosimilars Breakdown Data by Type 4.1 Global Peptides Biosimilars Historic Market Size by Type (2016-2021) 4.2 Global Peptides Biosimilars Forecasted Market Size by Type (2022-2027) 5 Peptides Biosimilars Breakdown Data by Application 5.1 Global Peptides Biosimilars Historic Market Size by Application (2016-2021) 5.2 Global Peptides Biosimilars Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Peptides Biosimilars Market Size (2016-2027) 6.2 North America Peptides Biosimilars Market Size by Type 6.2.1 North America Peptides Biosimilars Market Size by Type (2016-2021) 6.2.2 North America Peptides Biosimilars Market Size by Type (2022-2027) 6.2.3 North America Peptides Biosimilars Market Size by Type (2016-2027) 6.3 North America Peptides Biosimilars Market Size by Application 6.3.1 North America Peptides Biosimilars Market Size by Application (2016-2021) 6.3.2 North America Peptides Biosimilars Market Size by Application (2022-2027) 6.3.3 North America Peptides Biosimilars Market Size by Application (2016-2027) 6.4 North America Peptides Biosimilars Market Size by Country 6.4.1 North America Peptides Biosimilars Market Size by Country (2016-2021) 6.4.2 North America Peptides Biosimilars Market Size by Country (2022-2027) 6.4.3 United States 6.4.3 Canada 7 Europe 7.1 Europe Peptides Biosimilars Market Size (2016-2027) 7.2 Europe Peptides Biosimilars Market Size by Type 7.2.1 Europe Peptides Biosimilars Market Size by Type (2016-2021) 7.2.2 Europe Peptides Biosimilars Market Size by Type (2022-2027) 7.2.3 Europe Peptides Biosimilars Market Size by Type (2016-2027) 7.3 Europe Peptides Biosimilars Market Size by Application 7.3.1 Europe Peptides Biosimilars Market Size by Application (2016-2021) 7.3.2 Europe Peptides Biosimilars Market Size by Application (2022-2027) 7.3.3 Europe Peptides Biosimilars Market Size by Application (2016-2027) 7.4 Europe Peptides Biosimilars Market Size by Country 7.4.1 Europe Peptides Biosimilars Market Size by Country (2016-2021) 7.4.2 Europe Peptides Biosimilars Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Peptides Biosimilars Market Size (2016-2027) 8.2 Asia-Pacific Peptides Biosimilars Market Size by Type 8.2.1 Asia-Pacific Peptides Biosimilars Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Peptides Biosimilars Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Peptides Biosimilars Market Size by Type (2016-2027) 8.3 Asia-Pacific Peptides Biosimilars Market Size by Application 8.3.1 Asia-Pacific Peptides Biosimilars Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Peptides Biosimilars Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Peptides Biosimilars Market Size by Application (2016-2027) 8.4 Asia-Pacific Peptides Biosimilars Market Size by Region 8.4.1 Asia-Pacific Peptides Biosimilars Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Peptides Biosimilars Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Peptides Biosimilars Market Size (2016-2027) 9.2 Latin America Peptides Biosimilars Market Size by Type 9.2.1 Latin America Peptides Biosimilars Market Size by Type (2016-2021) 9.2.2 Latin America Peptides Biosimilars Market Size by Type (2022-2027) 9.2.3 Latin America Peptides Biosimilars Market Size by Type (2016-2027) 9.3 Latin America Peptides Biosimilars Market Size by Application 9.3.1 Latin America Peptides Biosimilars Market Size by Application (2016-2021) 9.3.2 Latin America Peptides Biosimilars Market Size by Application (2022-2027) 9.3.3 Latin America Peptides Biosimilars Market Size by Application (2016-2027) 9.4 Latin America Peptides Biosimilars Market Size by Country 9.4.1 Latin America Peptides Biosimilars Market Size by Country (2016-2021) 9.4.2 Latin America Peptides Biosimilars Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Peptides Biosimilars Market Size (2016-2027) 10.2 Middle East & Africa Peptides Biosimilars Market Size by Type 10.2.1 Middle East & Africa Peptides Biosimilars Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Peptides Biosimilars Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Peptides Biosimilars Market Size by Type (2016-2027) 10.3 Middle East & Africa Peptides Biosimilars Market Size by Application 10.3.1 Middle East & Africa Peptides Biosimilars Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Peptides Biosimilars Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Peptides Biosimilars Market Size by Application (2016-2027) 10.4 Middle East & Africa Peptides Biosimilars Market Size by Country 10.4.1 Middle East & Africa Peptides Biosimilars Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Peptides Biosimilars Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Sandoz 11.1.1 Sandoz Company Details 11.1.2 Sandoz Business Overview 11.1.3 Sandoz Peptides Biosimilars Introduction 11.1.4 Sandoz Revenue in Peptides Biosimilars Business (2016-2021) 11.1.5 Sandoz Recent Development 11.2 Pfizer 11.2.1 Pfizer Company Details 11.2.2 Pfizer Business Overview 11.2.3 Pfizer Peptides Biosimilars Introduction 11.2.4 Pfizer Revenue in Peptides Biosimilars Business (2016-2021) 11.2.5 Pfizer Recent Development 11.3 Teva Pahrmaceutical 11.3.1 Teva Pahrmaceutical Company Details 11.3.2 Teva Pahrmaceutical Business Overview 11.3.3 Teva Pahrmaceutical Peptides Biosimilars Introduction 11.3.4 Teva Pahrmaceutical Revenue in Peptides Biosimilars Business (2016-2021) 11.3.5 Teva Pahrmaceutical Recent Development 11.4 Celltrion 11.4.1 Celltrion Company Details 11.4.2 Celltrion Business Overview 11.4.3 Celltrion Peptides Biosimilars Introduction 11.4.4 Celltrion Revenue in Peptides Biosimilars Business (2016-2021) 11.4.5 Celltrion Recent Development 11.5 Biocon 11.5.1 Biocon Company Details 11.5.2 Biocon Business Overview 11.5.3 Biocon Peptides Biosimilars Introduction 11.5.4 Biocon Revenue in Peptides Biosimilars Business (2016-2021) 11.5.5 Biocon Recent Development 11.6 Amgen 11.6.1 Amgen Company Details 11.6.2 Amgen Business Overview 11.6.3 Amgen Peptides Biosimilars Introduction 11.6.4 Amgen Revenue in Peptides Biosimilars Business (2016-2021) 11.6.5 Amgen Recent Development 11.7 Samsung Biologics 11.7.1 Samsung Biologics Company Details 11.7.2 Samsung Biologics Business Overview 11.7.3 Samsung Biologics Peptides Biosimilars Introduction 11.7.4 Samsung Biologics Revenue in Peptides Biosimilars Business (2016-2021) 11.7.5 Samsung Biologics Recent Development 11.8 Mylan 11.8.1 Mylan Company Details 11.8.2 Mylan Business Overview 11.8.3 Mylan Peptides Biosimilars Introduction 11.8.4 Mylan Revenue in Peptides Biosimilars Business (2016-2021) 11.8.5 Mylan Recent Development 11.9 Dr. Reddy's Laboratories 11.9.1 Dr. Reddy's Laboratories Company Details 11.9.2 Dr. Reddy's Laboratories Business Overview 11.9.3 Dr. Reddy's Laboratories Peptides Biosimilars Introduction 11.9.4 Dr. Reddy's Laboratories Revenue in Peptides Biosimilars Business (2016-2021) 11.9.5 Dr. Reddy's Laboratories Recent Development 11.10 Stada Arzneimittel AG 11.10.1 Stada Arzneimittel AG Company Details 11.10.2 Stada Arzneimittel AG Business Overview 11.10.3 Stada Arzneimittel AG Peptides Biosimilars Introduction 11.10.4 Stada Arzneimittel AG Revenue in Peptides Biosimilars Business (2016-2021) 11.10.5 Stada Arzneimittel AG Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Peptides Biosimilars Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Glucagon Table 3. Key Players of Calcitonin Table 4. Global Peptides Biosimilars Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 5. Global Peptides Biosimilars Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global Peptides Biosimilars Market Size by Regions (2016-2021) & (US$ Million) Table 7. Global Peptides Biosimilars Market Share by Regions (2016-2021) Table 8. Global Peptides Biosimilars Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 9. Global Peptides Biosimilars Market Share by Regions (2022-2027) Table 10. Peptides Biosimilars Market Trends Table 11. Peptides Biosimilars Market Drivers Table 12. Peptides Biosimilars Market Challenges Table 13. Peptides Biosimilars Market Restraints Table 14. Global Peptides Biosimilars Revenue by Players (2016-2021) & (US$ Million) Table 15. Global Peptides Biosimilars Market Share by Players (2016-2021) Table 16. Global Top Peptides Biosimilars Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Peptides Biosimilars as of 2020) Table 17. Ranking of Global Top Peptides Biosimilars Companies by Revenue (US$ Million) in 2020 Table 18. Global 5 Largest Players Market Share by Peptides Biosimilars Revenue (CR5 and HHI) & (2016-2021) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Peptides Biosimilars Product Solution and Service Table 21. Date of Enter into Peptides Biosimilars Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Peptides Biosimilars Market Size by Type (2016-2021) (US$ Million) Table 24. Global Peptides Biosimilars Revenue Market Share by Type (2016-2021) Table 25. Global Peptides Biosimilars Forecasted Market Size by Type (2022-2027) (US$ Million) Table 26. Global Peptides Biosimilars Revenue Market Share by Type (2022-2027) & (US$ Million) Table 27. Global Peptides Biosimilars Market Size Share by Application (2016-2021) & (US$ Million) Table 28. Global Peptides Biosimilars Revenue Market Share by Application (2016-2021) Table 29. Global Peptides Biosimilars Forecasted Market Size by Application (2022-2027) (US$ Million) Table 30. Global Peptides Biosimilars Revenue Market Share by Application (2022-2027) & (US$ Million) Table 31. North America Peptides Biosimilars Market Size by Type (2016-2021) (US$ Million) Table 32. North America Peptides Biosimilars Market Size by Type (2022-2027) & (US$ Million) Table 33. North America Peptides Biosimilars Market Size by Application (2016-2021) (US$ Million) Table 34. North America Peptides Biosimilars Market Size by Application (2022-2027) & (US$ Million) Table 35. North America Peptides Biosimilars Market Size by Country (2016-2021) & (US$ Million) Table 36. North America Peptides Biosimilars Market Size by Country (2022-2027) & (US$ Million) Table 37. Europe Peptides Biosimilars Market Size by Type (2016-2021) (US$ Million) Table 38. Europe Peptides Biosimilars Market Size by Type (2022-2027) & (US$ Million) Table 39. Europe Peptides Biosimilars Market Size by Application (2016-2021) (US$ Million) Table 40. Europe Peptides Biosimilars Market Size by Application (2022-2027) & (US$ Million) Table 41. Europe Peptides Biosimilars Market Size by Country (2016-2021) & (US$ Million) Table 42. Europe Peptides Biosimilars Market Size by Country (2022-2027) & (US$ Million) Table 43. Asia-Pacific Peptides Biosimilars Market Size by Type (2016-2021) (US$ Million) Table 44. Asia-Pacific Peptides Biosimilars Market Size by Type (2022-2027) & (US$ Million) Table 45. Asia-Pacific Peptides Biosimilars Market Size by Application (2016-2021) (US$ Million) Table 46. Asia-Pacific Peptides Biosimilars Market Size by Application (2022-2027) & (US$ Million) Table 47. Asia-Pacific Peptides Biosimilars Market Size by Region (2016-2021) & (US$ Million) Table 48. Asia-Pacific Peptides Biosimilars Market Size by Region (2022-2027) & (US$ Million) Table 49. Latin America Peptides Biosimilars Market Size by Type (2016-2021) (US$ Million) Table 50. Latin America Peptides Biosimilars Market Size by Type (2022-2027) & (US$ Million) Table 51. Latin America Peptides Biosimilars Market Size by Application (2016-2021) (US$ Million) Table 52. Latin America Peptides Biosimilars Market Size by Application (2022-2027) & (US$ Million) Table 53. Latin America Peptides Biosimilars Market Size by Country (2016-2021) & (US$ Million) Table 54. Latin America Peptides Biosimilars Market Size by Country (2022-2027) & (US$ Million) Table 55. Middle East & Africa Peptides Biosimilars Market Size by Type (2016-2021) (US$ Million) Table 56. Middle East & Africa Peptides Biosimilars Market Size by Type (2022-2027) & (US$ Million) Table 57. Middle East & Africa Peptides Biosimilars Market Size by Application (2016-2021) (US$ Million) Table 58. Middle East & Africa Peptides Biosimilars Market Size by Application (2022-2027) & (US$ Million) Table 59. Middle East & Africa Peptides Biosimilars Market Size by Country (2016-2021) & (US$ Million) Table 60. Middle East & Africa Peptides Biosimilars Market Size by Country (2022-2027) & (US$ Million) Table 61. Sandoz Company Details Table 62. Sandoz Business Overview Table 63. Sandoz Peptides Biosimilars Product Table 64. Sandoz Revenue in Peptides Biosimilars Business (2016-2021) & (US$ Million) Table 65. Sandoz Recent Development Table 66. Pfizer Company Details Table 67. Pfizer Business Overview Table 68. Pfizer Peptides Biosimilars Product Table 69. Pfizer Revenue in Peptides Biosimilars Business (2016-2021) & (US$ Million) Table 70. Pfizer Recent Development Table 71. Teva Pahrmaceutical Company Details Table 72. Teva Pahrmaceutical Business Overview Table 73. Teva Pahrmaceutical Peptides Biosimilars Product Table 74. Teva Pahrmaceutical Revenue in Peptides Biosimilars Business (2016-2021) & (US$ Million) Table 75. Teva Pahrmaceutical Recent Development Table 76. Celltrion Company Details Table 77. Celltrion Business Overview Table 78. Celltrion Peptides Biosimilars Product Table 79. Celltrion Revenue in Peptides Biosimilars Business (2016-2021) & (US$ Million) Table 80. Celltrion Recent Development Table 81. Biocon Company Details Table 82. Biocon Business Overview Table 83. Biocon Peptides Biosimilars Product Table 84. Biocon Revenue in Peptides Biosimilars Business (2016-2021) & (US$ Million) Table 85. Biocon Recent Development Table 86. Amgen Company Details Table 87. Amgen Business Overview Table 88. Amgen Peptides Biosimilars Product Table 89. Amgen Revenue in Peptides Biosimilars Business (2016-2021) & (US$ Million) Table 90. Amgen Recent Development Table 91. Samsung Biologics Company Details Table 92. Samsung Biologics Business Overview Table 93. Samsung Biologics Peptides Biosimilars Product Table 94. Samsung Biologics Revenue in Peptides Biosimilars Business (2016-2021) & (US$ Million) Table 95. Samsung Biologics Recent Development Table 96. Mylan Company Details Table 97. Mylan Business Overview Table 98. Mylan Revenue in Peptides Biosimilars Business (2016-2021) & (US$ Million) Table 99. Mylan Recent Development Table 100. Dr. Reddy's Laboratories Company Details Table 101. Dr. Reddy's Laboratories Business Overview Table 102. Dr. Reddy's Laboratories Peptides Biosimilars Product Table 103. Dr. Reddy's Laboratories Revenue in Peptides Biosimilars Business (2016-2021) & (US$ Million) Table 104. Dr. Reddy's Laboratories Recent Development Table 105. Stada Arzneimittel AG Company Details Table 106. Stada Arzneimittel AG Business Overview Table 107. Stada Arzneimittel AG Peptides Biosimilars Product Table 108. Stada Arzneimittel AG Revenue in Peptides Biosimilars Business (2016-2021) & (US$ Million) Table 109. Stada Arzneimittel AG Recent Development Table 110. Research Programs/Design for This Report Table 111. Key Data Information from Secondary Sources Table 112. Key Data Information from Primary Sources List of Figures Figure 1. Global Peptides Biosimilars Market Share by Type: 2020 VS 2027 Figure 2. Glucagon Features Figure 3. Calcitonin Features Figure 4. Global Peptides Biosimilars Market Share by Application: 2020 VS 2027 Figure 5. Oncology Case Studies Figure 6. Chronic Diseases Case Studies Figure 7. Autoimmune Diseases Case Studies Figure 8. Blood Disorders Case Studies Figure 9. Growth Hormone Deficiency Case Studies Figure 10. Infectious Diseases Case Studies Figure 11. Other Diseases Case Studies Figure 12. Peptides Biosimilars Report Years Considered Figure 13. Global Peptides Biosimilars Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 14. Global Peptides Biosimilars Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 15. Global Peptides Biosimilars Market Share by Regions: 2020 VS 2027 Figure 16. Global Peptides Biosimilars Market Share by Regions (2022-2027) Figure 17. Global Peptides Biosimilars Market Share by Players in 2020 Figure 18. Global Top Peptides Biosimilars Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Peptides Biosimilars as of 2020 Figure 19. The Top 10 and 5 Players Market Share by Peptides Biosimilars Revenue in 2020 Figure 20. Global Peptides Biosimilars Revenue Market Share by Type (2016-2021) Figure 21. Global Peptides Biosimilars Revenue Market Share by Type (2022-2027) Figure 22. North America Peptides Biosimilars Market Size YoY Growth (2016-2027) & (US$ Million) Figure 23. North America Peptides Biosimilars Market Share by Type (2016-2027) Figure 24. North America Peptides Biosimilars Market Share by Application (2016-2027) Figure 25. North America Peptides Biosimilars Market Share by Country (2016-2027) Figure 26. United States Peptides Biosimilars Market Size YoY Growth (2016-2027) & (US$ Million) Figure 27. Canada Peptides Biosimilars Market Size YoY Growth (2016-2027) & (US$ Million) Figure 28. Europe Peptides Biosimilars Market Size YoY Growth (2016-2027) & (US$ Million) Figure 29. Europe Peptides Biosimilars Market Share by Type (2016-2027) Figure 30. Europe Peptides Biosimilars Market Share by Application (2016-2027) Figure 31. Europe Peptides Biosimilars Market Share by Country (2016-2027) Figure 32. Germany Peptides Biosimilars Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. France Peptides Biosimilars Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. U.K. Peptides Biosimilars Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Italy Peptides Biosimilars Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Russia Peptides Biosimilars Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Nordic Peptides Biosimilars Market Size YoY Growth (2016-2027) & (US$ Million) Figure 38. Asia-Pacific Peptides Biosimilars Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. Asia-Pacific Peptides Biosimilars Market Share by Type (2016-2027) Figure 40. Asia-Pacific Peptides Biosimilars Market Share by Application (2016-2027) Figure 41. Asia-Pacific Peptides Biosimilars Market Share by Region (2016-2027) Figure 42. China Peptides Biosimilars Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Japan Peptides Biosimilars Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. South Korea Peptides Biosimilars Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Southeast Asia Peptides Biosimilars Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. India Peptides Biosimilars Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. Australia Peptides Biosimilars Market Size YoY Growth (2016-2027) & (US$ Million) Figure 48. Latin America Peptides Biosimilars Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. Latin America Peptides Biosimilars Market Share by Type (2016-2027) Figure 50. Latin America Peptides Biosimilars Market Share by Application (2016-2027) Figure 51. Latin America Peptides Biosimilars Market Share by Country (2016-2027) Figure 52. Mexico Peptides Biosimilars Market Size YoY Growth (2016-2027) & (US$ Million) Figure 53. Brazil Peptides Biosimilars Market Size YoY Growth (2016-2027) & (US$ Million) Figure 54. Middle East & Africa Peptides Biosimilars Market Size YoY Growth (2016-2027) & (US$ Million) Figure 55. Middle East & Africa Peptides Biosimilars Market Share by Type (2016-2027) Figure 56. Middle East & Africa Peptides Biosimilars Market Share by Application (2016-2027) Figure 57. Middle East & Africa Peptides Biosimilars Market Share by Country (2016-2027) Figure 58. Turkey Peptides Biosimilars Market Size YoY Growth (2016-2027) & (US$ Million) Figure 59. Saudi Arabia Peptides Biosimilars Market Size YoY Growth (2016-2027) & (US$ Million) Figure 60. UAE Peptides Biosimilars Market Size YoY Growth (2016-2027) & (US$ Million) Figure 61. Sandoz Revenue Growth Rate in Peptides Biosimilars Business (2016-2021) Figure 62. Pfizer Revenue Growth Rate in Peptides Biosimilars Business (2016-2021) Figure 63. Teva Pahrmaceutical Revenue Growth Rate in Peptides Biosimilars Business (2016-2021) Figure 64. Celltrion Revenue Growth Rate in Peptides Biosimilars Business (2016-2021) Figure 65. Biocon Revenue Growth Rate in Peptides Biosimilars Business (2016-2021) Figure 66. Amgen Revenue Growth Rate in Peptides Biosimilars Business (2016-2021) Figure 67. Samsung Biologics Revenue Growth Rate in Peptides Biosimilars Business (2016-2021) Figure 68. Mylan Revenue Growth Rate in Peptides Biosimilars Business (2016-2021) Figure 69. Dr. Reddy's Laboratories Revenue Growth Rate in Peptides Biosimilars Business (2016-2021) Figure 70. Stada Arzneimittel AG Revenue Growth Rate in Peptides Biosimilars Business (2016-2021) Figure 71. Bottom-up and Top-down Approaches for This Report Figure 72. Data Triangulation Figure 73. Key Executives Interviewed

Sandoz Pfizer Teva Pahrmaceutical Celltrion Biocon Amgen Samsung Biologics Mylan Dr. Reddy's Laboratories Stada Arzneimittel AG